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Supporting Online Material 
Materials and Methods 
All cloning procedures for the biopolymer templates as well as the monomeric 
kinesin motor constructs were carried out in the E. coli strain XL1-Blue (Stratagene).  
The resulting plasmids were transformed into competent BL21 cells which were used as 
the expression host strain.  The scaffold proteins and the motors were expressed and 
purified separately from one another.  Motors assemblies were formed in solution by 
incubating the motor and the scaffolds in solution prior to measurments.  Microtubules 
were formed by polymerizing phosphocellulose-purified tubulin that was either purified 
from cow brain (1) or purchased from Cytoskeleton.   
 
Construction of (ZR-ELF5)n Plasmids.  Genes encoding the artificial protein templates 
were constructed from synthetic DNA oligomers.  The sequences of the plasmids 
produced from all cloning steps were verified using restriction mapping and DNA 
sequence analysis.  
Construction of the polymer genes began by modifying a pQE60 vector (Qiagen).  
Two BanI restriction sites that are outside of the cloning region were removed using 
PCR, and a single BanI restriction was inserted into the cloning region by ligation of a 
synthetic oligonucleotide between the BamHI and BglII restriction sites of pQE60.  This 
vector was designated pMD1.  These modifications allowed a 75-bp oligonucleotide that 
encodes a single ELF element, (VPGVG)2VPGFG(VPGVG)2, to be ligated into the 
newly introduced BanI restriction site. After sequence verification, the ELF cassette was 
isolated by BanI digestion, and then self-ligated to form multimerized ELF cassettes 
containing 2 to 7 ELF repeats.  The ELF5 cassette was isolated from an agarose gel, and 
ligated back into pMD1.  The genes encoding ZR were constructed by assembling 
synthetic oligoneucleotides through PCR as previously reported (2).  The 140-bp 
fragment encoding ZR was isolated using BamHI digestion and ligated into pMD1 at the 
5’ side of the ELF5 gene.   The resulting ZR-ELF5 gene was PCR amplified from this 
vector.  This cloning step modified the 3’ end of the ZR-ELF5 gene by introducing a 
codon encoding a cysteine and a stop codon.  This PCR product was excised by EcoRI 
and HindIII digestion and then ligated between the EcoRI and HindIII sites of pQE32 
(Qiagen).   
In order to prepare genes encoding for the dimeric (ZR-ELF5)2 and trimeric (ZR-
ELF5)3 polymers, three additional PCR reactions were performed. These reactions 
modified either the 5’, the 3’, or both ends of the monomeric ZR-ELF5 fragment by 
introducing NheI restriction sites.    All PCR products were NheI digested, while the 5’ 
and 3’ modified ZR-ELF5 fragments were also SphI and HindIII digested respectively.  In 
a single ligation reaction, the corresponding fragments were ligated together to form 
either a 1077-bp fragment encoding (ZR-ELF5)2, or a 1611-bp fragment encoding (ZR-
ELF5)3,  and inserted between the SphI and HindIII restriction sites of pQE70.  This 
synthetic step introduces four amino acids(KASK) between ZR-ELF5 units.  Amino acid 








ELF:   (VPGVG)2VPGFG(VPGVG)2 
ZR:  LEIRAAALRRRNTALRTRVAELRQRVQRVQRLRNEVSQYETRGPL 
ZE:  LEIEAAALEQENTALETEVAELEQEVQRLENIVSQYRTRFGPL 
ZR-ELF5 MDPLK-(ZR-ELF5)-GVGC 
(ZR-ELF5)2 MHPLK-(ZR-ELF5)-KASK- (ZR-ELF5)-GVGC 
(ZR-ELF5)3     MHPLK-(ZR-ELF5)-[KASK-(ZR-ELF5)]2-GVGC 
Table S1.  Final DNA constructs used to synthesize polymeric scaffolds 
 
Construction and Expression of the K350-ZE plasmid:  The minimal motor domain 
containing the first 350 N-terminal  amino acids of the Drosophila kinesin was cloned out 
of pEY4 (3) using PCR amplification.  The pEY4 plasmid was provided kindly by Jeff 
Gelles. The 5’-primer (5’- ACATGCATGCCCGCGGAACGAGAGATTCCCGCCG-3’) 
introduced a SphI site at the translational initiation site.  The 3’-primer (5’-
CGCGGATCCATAGCGTCGCTTCCATTCCTCGGCAGTAAG-3’) was complementary to amino 
acids 320-350.  This primer introduces a BamHI site after amino acid 350 in the neck 
region of the motor.  A proofreading polymerase (Pfu turbo, Stratagene) was used during 
amplification to reduce the frequency of mutation.  After digestion with SphI and BamHI, 
the PCR product was ligated into a pQE70 expression vector.  The ZE cassette was 
inserted into the BamHI site at the 3’ end of the motor sequence.  The final K350-ZE 
construct encodes the first 350 amino acids of the motor, 44 amino acids of ZE and a C-
terminal 6xHis tag.   
Expression and purification of the K350-ZE motor were carried out essentially as 
described by Case et al. (4) with minor modifications.  Protein synthesis and purification 
were confirmed by SDS-PAGE analysis.  For some experiments, a round of mictrotubule 
affinity purification was performed.  Motor protein concentrations were determined using 
the Bradford method.   
 
Bacterial Expression and Purification of (ZR-ELF5)n  Proteins.  Preliminary bacterial 
expression and purification of ZR-ELF5 failed to produce the full length monomer 
constructs due to proteolytic degradation of the basic zipper.  The use of denaturing 
purification conditions did not prevent proteolysis, indicating that proteolytic cleavage of 
the basic zipper occurs in vivo.  To overcome this problem, the (ZR-ELF5)n genes were 
coexpressed with a gene that encodes ZE-6xHis.  The ZE-6xHis gene was obtained by 
PCR amplification, and includes the bacteriophage T5 promoter of the pQE plasmids.  
The PCR product was HindIII digested and ligated into pREP4 (Qiagen) at a HindIII site.  
Both plasmids were cotransformed into E. coli Strain BL21 and expressed simultaneously 
upon addition of 1 mM isopropyl-β-thiogalactoside (IPTG).  Expressing these genes 
together allows formation of the ZE / ZR coiled-coil complex in vivo.  As a complex these 
polypeptides are highly resistant to proteolysis, and full length constructs are obtained. 
The two plasmid system described above was used for bacterial expression of all 
three polymer scaffolds.  During a typical synthesis, cell cultures were grown at 37oC in 2 
L of TB medium [24 g of casein hydrolysate, 12 g of yeast extract, 3 g/L glycerol,  
KH2PO4 K2HPO4], and antibiotics [200 mg/L ampicillin and 35 mg/L kanamysin].  Once 
the cultures reached optical densities (600nm, OD600) greater than 1, protein expression 
was induced for a period of 8 hours. The cells were then pelleted (4,000g for 10 min), 
resuspended in lysis buffer [8 M urea, 0.1 M Na2HPO4 (pH 8.0)], and lysed overnight 
with vigorous agitation.  The cell lysate was clarified by centrifugation and applied to a 
column of nickelnitrilotriacetic acid (Ni2+-NTA) resin.  After, washing with 
approximately 3 column volumes of lysis buffer, 1 column volume of a buffer containing 
6 M guanidine-HCl  and 0.1 M Na2HPO4 (pH 8) was added, and allowed to incubate for 
10 min.   During this step, the zippers in the heterodimeric ZE/ZR complex disassociate, 
allowing the ZE-6xHis and (ZR-ELF5)n proteins to be separated.  The majority of the ZE-
His oligopeptide remains on the column, while the eluted (ZR-ELF5)n solutions are 
collected.   Solutions of monomeric ZR-ELF5 polymers were dialyzed against ddH2O 
using an 8,000 MW cutoff membrane, while the larger molecular weights of the dimeric 
and trimeric polymers permitted the use of a larger, 14,000 MW, cutoff membrane.  After 
dialyzing the solution for 3 days with extensive water changes, protein impurities that 
precipitated from solution were removed by centrifugation (30,000g).  Proteins samples 
were frozen and lyophilized for storage at 4oC.   
Polymer stock solutions were made by resuspending the lyophilized polymers in 
8M urea at concentration of 10 mg/mL.  After a second round of dialysis against ddH2O, 
the solutions were clarified (30,000g), and frozen for storage at -20oC.  Purity of the stock 
solutions was determined using 9% tris-tricine gel electrophoresis and MALDI-TOF 
spectroscopy.  The amount of ZE-6xHis peptide that was carried over during purification 
was estimated by comparing the intensities of the ZE-6xHis and (ZR-ELF5)n bands that 
were separated on protein gels.  The ZE-His peptide typically comprised less than 15% of 
the total protein in a monomeric ZR-ELF5 polymer solutions.   The signal from the ZE-His 
peptide could not be distinguished from background for stock solutions of the dimeric 
(ZR-ELF5)2 and trimeric (ZR-ELF5)3 polymers, indicating these solutions contain only 
trace amounts of ZE-6xHis.  Any ZE-His protein that did elute with the sample using this 
protocol can be removed by resuspending the protein in  6 M guanidine-HCl  and 0.1 M 
Na2HPO4 (pH 8) and performing a second round of Ni2+-NTA purification. 
Polymers were labeled with biotin at their C-terminal cysteine using a PEO-
biotinmaleimide (Pierce) and standard maleimide labeling protocols (5). 
 
Measurement of ATPase Hydrolysis Rates.  ATPase assays were performed using a 
coupling system of pyruvate kinase and lactic dehydrogenase as previously reported (6).    
Reactions were carried out in 20 mM Tris-Cl (pH 7.0), 1 mM EGTA, 4 mM MgCl, 1 mM 
dithioerithritol and 1 mM ATP at room temperature.  The concentration of the motor in 
the final reaction mixtures ranged from 0.05 to 0.2 µM from assay to assay.  The 
concentrations of (ZR-ELF5)n polymers were selected to give a one to one stoichiometry 
between the ZR sites of the polymer and the motor.  The final reaction mixture, minus 
microtubules, was equilibrated to room temperature.  Reactions were then initiated by 
addition of microtubules.   
Reaction rates were adjusted to account for background hydrolysis of the 
microtubules and normalized for the motor concentration.  All assays were repeated using 
motor stocks prepared from multiple kinesin syntheses. A second round of microtubule 
affinity purification was used to verify that ATPase measurements are not limited by the 
percentage of active motor protein in solution (Table 1).    
 
Microtubule Gliding Velocities. Microtubule gliding was observed by monitoring 
the motions of rhodamine labelled microtubules (Cytoskeleton) on top of a 
motor/polymer coated coverslip using objective-based total internal reflectance 
microscopy.  The motor/polymer complexes were attached to the coverslip surface 
through a biotin streptavidin linkage.  Streptavidin coated reaction chambers were 
prepared as previously described (3).  Before introduction into the chambers, 
motor/polymer assemblies were prepared in solution by incubating a 5 to 20 fold excess 
of K350-ZE with biotin-labelled polymer templates for 20 min at 4oC.  After incubation, 
these solutions were perfused into the flow cells and then incubated for 20 min at 4oC.  A 
control experiment was performed using an unsaturated dimeric polymer.  Here, a 
motor/polymer solution was prepared using the dimeric polymer (ZR-ELF5)2, where the 
solution contained a three-fold excess of the ZR attachment sites.  In this case, the 
polymer/motor solutions were perfused into reaction chambers immediately after mixing 
the stock solutions, allowing attachment to the cover slip to compete with motor-polymer 
binding.  Multiple motor stock solutions, obtained from several kinesin syntheses and 
purifications were used in these assays.  Microtubule binding was not observed when 
either the polymers or neutravidin was omitted from the sample preparation. 
After binding the motor/polymer complexes to the glass surface, the chambers 
were rinsed with 1 mg/mL casein, and then briefly incubated with taxol stabilized 
microtubules.  Microtubule gliding was initiated by flushing with imaging buffer (80 mM 
Pipes, 1 mM EGTA, 4 mM MgCl2, 5 mM Mg-ATP 10 µM Taxol and an oxygen 
scavenger system).  Filament positions were recorded at 3 to 12 frames/sec using an 
Optronics camera outfitted with an intensifier.  Microtubule positions and velocities were 
measured using RETRAC software (available online at 
http://mc11.mcri.ac.uk/motorhome.html), or a using custom routine in ImageJ (available 
online at http://rsb.info.nih.gov/ij/). 
Temperature dependent assays were performed by controlling the temperature of 
the sample from both the top and bottom sides of the perfusion chamber.  This was 
accomplished by adjusting the temperature of the oil immersion objective with a metal 
heating/cooling block.  A second block contacted the back side of the sample.  Both 
heating/cooling elements were connected in series to a temperature controlled circulating 
water bath.  The temperature was measured at the objective using a silicon diode 
connected to a Lake Shore 340 temperature control.  Several K-type thermocouples were 
placed around the sample and heating / cooling blocks to detect any thermal gradients.   
The temperature of the apparatus was stable to less than 50 mK over the full range of 
temperatures used.  
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